We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pharmanest Initiates Phase II Study of SHACT

News   Jun 19, 2012

 
Pharmanest Initiates Phase II Study of SHACT
 
 
 

RELATED ARTICLES

GW Pharmaceuticals Receives Positive NICE Recommendation for EPIDYOLEX (Cannabidiol)

News

GW Pharmaceuticals plc announces that two of its medicines, EPIDYOLEX (cannabidiol) oral solution and Sativex (nabiximols), have been recommended by the UK’s National Institute for Health and Care Excellence (NICE) to receive routine reimbursement from NHS England.

READ MORE

Novel “Fizzy” Patch Could Provide Contraceptive Protection to Women

News

Scientists have created a reversible contraceptive microneedle patch that is able to slowly release the hormone levonorgestrel, through the skin. The study was published November 6, 2019, in Science Advances.

READ MORE

Researchers Highlight Heart Risks Linked to Vaping

News

A new review of the research so far finds growing evidence that vaping can harm the heart and blood vessels. In addition to nicotine, e-cigarettes contain particulate matter, metals and flavorings – all of which could contribute to cardiovascular problems, researchers say.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE